Calithera Bioscience After Hours

Calithera Biosciences, Inc. Common Stock (CALA) After …

https://www.nasdaq.com/market-activity/stocks/cala/after-hours

Calithera Biosciences, Inc. Common Stock (CALA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.

CALA Stock Price | Calithera Biosciences Inc. Stock …

https://www.marketwatch.com/investing/stock/cala

Shares of Calithera Biosciences Inc. jumped 14.6% in premarket trading on Monday after the company said it received a Fast Track designation for its experimental treatment for …

Calithera | Targeting Cancer, Differently | Home

https://www.calithera.com/

Calithera is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted, small molecule therapies that disrupt cellular …

CALA - Calithera Biosciences Inc Stock quote - CNNMoney.com

https://money.cnn.com/quote/quote.html?symb=CALA

Find real-time CALA - Calithera Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business. CALA - Calithera Biosciences Inc Stock quote - …

Why Calithera Biosciences Stock Is Plunging Today

https://www.fool.com/investing/2021/01/04/why-calithera-biosciences-stock-is-plunging-today/

Calithera Biosciences to Liquidate >CALA - MarketWatch

https://www.marketwatch.com/story/calithera-biosciences-to-liquidate-cala-271673271410

Calithera Biosciences Inc. on Monday said its board approved a complete liquidation and dissolution of the clinical-stage biopharmaceutical company that will wipe …

Calithera Biosciences Stock Nosedives On Complete Liquidation, …

https://finance.yahoo.com/news/calithera-biosciences-stock-nosedives-complete-151802147.html

Calithera Biosciences Inc (NASDAQ: CALA) announced that its Board of Directors has determined that it is in the best interests of its shareholders to dissolve the …

Calithera Biosciences Announces Board Approval of Complete …

https://finance.yahoo.com/news/calithera-biosciences-announces-board-approval-130000765.html

SOUTH SAN FRANCISCO, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), today announced that its Board of …

Calithera | Tumor Metabolism and Tumor Immunology | Contact

https://www.calithera.com/contact-us/

Calithera Biosciences, Inc. 343 Oyster Point Blvd, Suite 200. South San Francisco, CA 94080. +1 650 870 1000.

Calithera Biosciences Shares Progress in Sapanisertib and

https://www.globenewswire.com/news-release/2022/07/13/2479319/32478/en/Calithera-Biosciences-Shares-Progress-in-Sapanisertib-and-Mivavotinib-Clinical-Programs-at-Upcoming-Lung-Cancer-and-Lymphoma-Conferences.html

Calithera Biosciences is a clinical-stage, precision oncology biopharmaceutical company developing targeted therapies to redefine treatment for …